Bayer CropScience (506285) Q1 24/25 earnings summary

Executive summary

• Unaudited financial results for the quarter ended June 30, 2024, were approved by the Board on August 8, 2024.

• The business operates in a single segment, "Agri Care," and is subject to seasonal fluctuations.

Financial highlights

• Revenue from operations for Q1 FY25 was ₹16,312 million, up from ₹7,915 million in the previous quarter and slightly down from ₹16,587 million year-over-year.

• Profit before tax for the quarter was ₹3,158 million, compared to ₹1,054 million in the previous quarter and ₹4,061 million in the same quarter last year.

• Net profit for the quarter was ₹2,542 million, up from ₹960 million sequentially but down from ₹3,285 million year-over-year.

• Earnings per share (basic and diluted, not annualised) stood at ₹56.56 for the quarter.

Outlook and guidance

• Quarterly figures are not necessarily indicative of full-year performance due to the seasonal nature of the business.